Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Pauwels · SciRah

Researcher profile · Semantic Scholar

R. Pauwels

Share profile

R. Pauwels — researcher profile on SciRah

h-index: 7
Works: 24
Citations: 140

Most-cited papers

Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-Analysis of 1317 Patients From 14 Studies.
R. Pauwels, C. Janneke van der Woude, D. Nieboer, E. Steyerberg +20 more
2021Clinical Gastroenterology and Hepatology32 citations Open access
Semantic Scholar
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice
E. Proietti, R. Pauwels, A. D. de Vries, E. Orecchini +5 more
2023International Journal of Tryptophan Research18 citations Open access
Semantic Scholar
Ustekinumab Tissue and Serum Levels in Patients With Crohn’s Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction
E. Proietti, R. Pauwels, C. J. van der Woude, M. Doukas +6 more
2022Inflammatory Bowel Diseases17 citations Open access
Semantic Scholar
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
R. V. van Linschoten, F. Jansen, R. Pauwels, L. Smits +24 more
2023The Lancet Gastroenterology and Hepatology13 citations Open access
Semantic Scholar
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease
R. Pauwels, E. Proietti, C. J. van der Woude, L. Oudijk +5 more
2021Inflammatory Bowel Diseases12 citations Open access
Semantic Scholar
Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
R. Pauwels, C. J. van der Woude, N. Erler, A. D. de Vries
2020Therapeutic Advances in Gastroenterology10 citations Open access
Semantic Scholar
Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice
R. Pauwels, A. D. de Vries, C. J. van der Woude
2020Journal of Gastroenterology and Hepatology9 citations Open access
Semantic Scholar
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies
S. ten Bokkel Huinink, Doranne Thomassen, E. Steyerberg, R. Pauwels +16 more
2023Journal of Crohn's & Colitis7 citations Open access
Semantic Scholar
Lengthening adalimumab dosing interval in quiescent Crohn’s disease patients: protocol for the pragmatic randomised non-inferiority LADI study
L. Smits, R. Pauwels, W. Kievit, D. D. de Jong +3 more
2020BMJ Open6 citations Open access
Semantic Scholar
Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn’s disease
R. Pauwels, S. ten Bokkel Huinink, C. J. van der Woude, M. Doukas +2 more
2023Scandinavian Journal of Gastroenterology4 citations Open access
Semantic Scholar
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn’s Disease Patients in Stable Remission: The Randomized Controlled LADI Trial
F. Jansen, R. V. van Linschoten, W. Kievit, L. Smits +23 more
2023Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
Mo1887 – Ustekinumab Endoscopic Response At Week 16 is Associated with Early Normalization of Fecal Calprotectin After Induction
R. Pauwels, A. D. de Vries, J. Goet, N. Erler +1 more
2019Gastroenterology2 citations Open access
Semantic Scholar
Vedolizumab Induces Significantly Higher Endoscopic Remission Rates at Week 16 in Ulcerative Colitis as Compared to Crohn's Disease
R. Pauwels, A. D. de Vries, C. J. van der Woude
20172 citations
Semantic Scholar
P447 Vedolizumab induces significantly higher endoscopic remission rates at week 16 in ulcerative colitis as compared to Crohn's disease.
R. Pauwels, A. de Vries, C. J. van der Woude
2017Journal of Crohn's & Colitis2 citations
Semantic Scholar
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn’s Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
R. V. van Linschoten, F. Jansen, R. Pauwels, L. Smits +24 more
2024Digestive Diseases and Sciences1 citations Open access
Semantic Scholar
P138 Prediction model to safely cease anti-TNF therapy in Crohn’s disease: individual patient data meta-analysis (IPD-MA)
R. Pauwels, C. J. van der Woude, D. Nieboer, E. Steyerberg +14 more
2019Journal of Crohn's & Colitis1 citations
Semantic Scholar
537 – Fecal Calprotectin is an Early Predictor of Endoscopic Response and Histological Remission After the Start of Vedolizumab
R. Pauwels, A. D. de Vries, J. Goet, N. Erler +1 more
2019Gastroenterology1 citations
Semantic Scholar
Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease".
R. Pauwels, A. D. de Vries, C. Janneke van der Woude
2018Inflammatory Bowel Diseases1 citations
Semantic Scholar
The complex relationship between pelvic organ prolapse and urinary incontinence; does prolapse surgery without concomitant anti-incontinence surgery cure or induce stress and urge incontinence?
M. Vierhout, R. Pauwels, T. Smits, K. Kluivers +2 more
20111 citations
Semantic Scholar
P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial
R. V. van Linschoten, F. Jansen, R. Pauwels, L. Smits +24 more
2023Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
P414 Ustekinumab endoscopic response at Week 16 is associated with early normalisation of faecal calprotectin after induction
R. Pauwels, A. de Vries, J. Goet, N. Erler +1 more
2019Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
P362 Faecal calprotectin is an early predictor of endoscopic response and histological remission after the start of vedolizumab
R. Pauwels, A. de Vries, J. Goet, N. Erler +1 more
2019Journal of Crohn's & Colitis0 citations
Semantic Scholar
P433 Faecal calprotectin is correlated to endoscopic disease activity at Week 16 in IBD patients on vedolizumab therapy
R. Pauwels, A. de Vries, C. J. van der Woude
20180 citations Open access
Semantic Scholar
Abstracts of the 12th Congress of ECCO – European Crohn’s and Colitis Organisation
R. Pauwels, A. de Vries, C. J. van der Woude, Ashutosh Kumar Singh +5 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. D. de Vries×15
Invite
A. D. de Vries — researcher profile on SciRah
C. J. van der Woude×9
Invite
C. J. van der Woude — researcher profile on SciRah
A. de Vries×8
Invite
A. de Vries — researcher profile on SciRah
C. J. van der Woude×7
Invite
C. J. van der Woude — researcher profile on SciRah

C. Janneke van der Woude×6

Invite

C. Janneke van der Woude — researcher profile on SciRah

Invite

L. Smits — researcher profile on SciRah

Invite

W. Kievit — researcher profile on SciRah

D. D. de Jong×5

Invite

D. D. de Jong — researcher profile on SciRah

Invite

F. Hoentjen — researcher profile on SciRah

Invite

N. Erler — researcher profile on SciRah

R. V. van Linschoten×4

Invite

R. V. van Linschoten — researcher profile on SciRah

Invite

F. Jansen — researcher profile on SciRah